SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

RELEASING THE RESTRAINTS OF V gamma 9V delta 2 T-CELLS IN CANCER IMMUNOTHERAPY

Ridgley, L; Dalgleish, A; Bodman-Smith, M (2020) RELEASING THE RESTRAINTS OF V gamma 9V delta 2 T-CELLS IN CANCER IMMUNOTHERAPY. In: 35th Anniversary Annual Meeting (SITC 2020), JOURNAL FOR IMMUNOTHERAPY OF CANCER, 9th-14th November 2020.
SGUL Authors: Bodman-Smith, Mark Duncan Dalgleish, Angus George

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (53kB) | Preview
Item Type: Conference or Workshop Item (UNSPECIFIED)
Additional Information: © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: JOURNAL FOR IMMUNOTHERAPY OF CANCER
ISSN: 2051-1426
Dates:
DateEvent
9 November 2020Published
Publisher License: Creative Commons: Attribution 4.0
Web of Science ID: WOS:000616665301344
URI: https://openaccess.sgul.ac.uk/id/eprint/113014
Publisher's version: https://doi.org/10.1136/jitc-2020-SITC2020.0836

Actions (login required)

Edit Item Edit Item